Balogbog, Gilnert, Jr. D.
HRN: 21-34-64 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2022
CEFUROXIME 750MG (VIAL)
09/18/2022
09/25/2022
IVTT
205mg
Q8
Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes